心臓代謝疾患のリスクとの関節および時間的関節炎およびアテロジェニック・ディスリピデミアの関連: 長期コホート研究
PubMedで要約を見る
まとめ
この要約は機械生成です。システミックな炎症とアテロゲン性脱脂症は,心臓代謝疾患のリスクを共に増加させる. 炎症は不脂症に先行し,部分的に炎症とCMDの関係を媒介し,併合した危険因子を強調する.
科学分野
- 心臓病科
- 内分泌学
- 公衆衛生
背景
- 心臓代謝疾患 (CMD) のリスクは,全身性炎症と動脈性脂質不全によって影響を受けます.
- これらの要因の相互作用と時間的関係を理解することは,リスクの予測と予防に不可欠です.
研究 の 目的
- 組織性炎症 (C反応性タンパク質,CRPで測定される) とアテロゲン性不血症 (アテロゲン性血指数,AIPで測定される) とCMDリスクとの関連を調査する.
- 炎症と脂質不全の時間的な順序が CMD の後のリスクに影響するかどうかを判断する.
主な方法
- 心血管疾患や糖尿病のない78,206人の参加者を対象とした前向きなコホート研究.
- CRP (<1, 1-3, ≥3 mg/ L) とAIP (<0. 1, ≥0. 1) レベルによって分類された参加者.
- アソシエーションと時間的な関係を評価するために使用されたコックス比例ハザード回帰,クロスレイグ分析,およびメディエーション分析.
主要な成果
- CRP ≥3 mg/ LとAIP ≥0. 1は64%高いリスクを示した.
- クロスラグ分析では,システム性炎症 (CRP) は,逆よりも後続性動脈性脂質減少症 (AIP) を強く予測することが示された.
- 媒介分析では,アテロゲン性脂質不全が,全身性炎症と発生性CMDとの関連を部分的に媒介していたことが明らかになった (21. 52%の媒介).
結論
- 組織性炎症とアテロゲン性脂質不全症は,共同でCMDのリスクが高まります.
- 系統的炎症が先行し,アテロゲン性脂質不全症の発生に寄与する可能性があります.
- アテロゲン性脱脂症は,全身の炎症と心代謝疾患の発症の関係を部分的に媒介する.
関連する概念動画
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Overview
In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

